UNM:NYE-Unum Group (USD)

COMMON STOCK | Insurance - Life |

Last Closing

USD 81.61

Change

+2.78 (+3.53)%

Market Cap

N/A

Volume

2.00M

Analyst Target

USD 21.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-17 )

Largest Industry Peers for Insurance - Life

Symbol Name Price(Change) Market Cap
AFL Aflac Incorporated

+1.15 (+1.07%)

USD 59.26B
MET-PA MetLife Inc Preferred Stock Se..

+0.05 (+0.20%)

USD 47.88B
MET-PE MetLife Inc Preferred Stock Se..

+0.19 (+0.79%)

USD 42.42B
PRU Prudential Financial Inc

+1.80 (+1.66%)

USD 38.41B
PUK Prudential PLC ADR

+0.52 (+2.64%)

USD 24.05B
PRI Primerica Inc

+5.29 (+1.85%)

USD 9.49B
JXN Jackson Financial Inc

+0.60 (+0.72%)

USD 6.14B
FG F&G Annuities & Life Inc.

-0.06 (-0.14%)

USD 5.18B
ANG-PB American National Group Inc

+0.02 (+0.06%)

N/A
MET-PF MetLife Inc Preferred Stock Se..

+0.18 (+0.88%)

N/A

ETFs Containing UNM

FLI:CA CI U.S. & Canada Lifeco C.. 10.59 % 0.92 %

+0.38 (+1.43%)

CAD 0.09B
WTV WisdomTree Trust - Wisdom.. 1.24 % 0.00 %

+1.05 (+1.43%)

USD 0.76B
CVY Invesco Zacks Multi-Asset.. 1.06 % 0.65 %

+0.37 (+1.43%)

USD 0.11B
IVOV Vanguard S&P Mid-Cap 400 .. 0.86 % 0.20 %

+1.34 (+1.43%)

USD 0.87B
DFAT Dimensional U.S. Targeted.. 0.84 % 0.00 %

+0.60 (+1.43%)

USD 10.26B
2B77:XETRA iShares Ageing Population.. 0.81 % 0.00 %

+0.07 (+1.43%)

USD 0.50B
UIMS:XETRA UBS (Irl) ETF plc - UBS (.. 0.70 % 0.00 %

+0.16 (+1.43%)

USD 0.07B
WSCSRI:SW UBS (Irl) ETF plc - UBS (.. 0.70 % 0.00 %

+0.12 (+1.43%)

USD 0.50B
WSCR:LSE UBS (Irl) ETF plc - MSCI .. 0.69 % 0.00 %

+6.40 (+1.43%)

USD 0.01B
JMEE JPMorgan Market Expansion.. 0.54 % 0.00 %

+0.74 (+1.43%)

USD 1.69B
CSY8:F Credit Suisse Index Fund .. 0.53 % 0.00 %

+2.38 (+1.43%)

N/A
CSY8:XETRA UBS (Irl) ETF plc - MSCI .. 0.53 % 0.00 %

-0.42 (1.43%)

N/A
HWSC:LSE HSBC MSCI World Small Cap.. 0.38 % 0.00 %

+0.29 (+1.43%)

N/A
SDVY First Trust SMID Cap Risi.. 0.00 % 0.60 %

+0.29 (+1.43%)

USD 8.02B
XMVM Invesco S&P MidCap Value .. 0.00 % 0.39 %

+0.59 (+1.43%)

USD 0.25B
ZEUS:CA 0.00 % 0.73 %

N/A

N/A
AFMC First Trust Active Factor.. 0.00 % 0.00 %

+0.43 (+1.43%)

USD 0.04B
2B77:F iShares Ageing Population.. 0.00 % 0.00 %

+0.22 (+1.43%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Life) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.75% 80% B- 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.75% 80% B- 90% A-
Trailing 12 Months  
Capital Gain 57.21% 94% A 96% N/A
Dividend Return 2.32% 38% F 40% F
Total Return 59.54% 94% A 96% N/A
Trailing 5 Years  
Capital Gain 591.61% 100% F 95% A
Dividend Return 52.92% 92% A 81% B-
Total Return 644.53% 100% F 95% A
Average Annual (5 Year Horizon)  
Capital Gain 35.97% 89% A- 90% A-
Dividend Return 40.10% 89% A- 91% A-
Total Return 4.12% 69% C- 75% C
Risk Return Profile  
Volatility (Standard Deviation) 27.70% 56% F 38% F
Risk Adjusted Return 144.74% 100% F 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.